Health

HealthKFF Health News

Could Your Kid Benefit From Counseling? Experts Offer 3 Questions To Help You Decide

Anxious kids can benefit from counseling, but therapy demands a commitment of money and time. Therapists recommend using three criteria to help determine when challenging behavior rises to the level of needing professional help.

Lean L1h agoRead at KFF Health News

KFF Health NewsLean L1h ago

Trivia Nights, Valentine’s Cards: Overlooked Social Connections Can Prevent Suicide

STAT2h ago

A leader of the 2014 U.S. Ebola response compares then to now

STAT2h ago

STAT+: Wearables, and the flood of data they generate, inch closer to entering the clinic

STAT2h ago

Opinion: Ending animal testing could set back xenotransplantation just as the field is poised for a breakthrough

STAT2h ago

Opinion: Why STAT is sticking with ‘health care’ as two words

STAT2h ago

STAT+: Trump’s health care affordability czar touts Medicaid cuts to hospital leaders

NPRLean L1h ago

More Americans survive cancer. But the psychological impacts can persist for years

NPRLean L1h ago

GLP-1s appear to protect against cancer. Researchers are trying to figure out how

STAT3h ago

STAT+: GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6B

STAT5h ago

Alcohol study discarded by Trump officials is published in scientific journal

STAT14h ago

Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or rest

STAT14h ago

STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials

STAT19h ago

STAT+: UnitedHealthcare’s lactation billing feud, and fake strokes

STAT20h ago

STAT+: Novo underwhelmed by drug it once fought Pfizer for

STAT21h ago

STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more

STAT21h ago

STAT+: J&J spends $1 billion to enter KRAS race for cancer treatments

STAT22h ago

Major readouts from the annual diabetes conference

STAT22h ago

STAT+: Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rate

NPRLean L23h ago

In his book, self-described USAID 'whistleblower' talks about the agency and Ebola

KFF Health NewsLean L1d ago

MAHA’s Treatments for Autism: Camel’s Milk, Stem Cell Injections — And Spelling Therapy

NPRLean L1d ago

People love working from home. But does it love them back? A new study says no

NPRLean L1d ago

Can a vibrating belt help protect bones and muscle health?

KFF Health NewsLean L1d ago

Could Your Kid Benefit From Counseling? Experts Offer 3 Questions To Help You Decide

Could Your Kid Benefit From Counseling? Experts Offer 3 Questions To Help You Decide

Trivia Nights, Valentine’s Cards: Overlooked Social Connections Can Prevent Suicide

A leader of the 2014 U.S. Ebola response compares then to now

STAT+: Wearables, and the flood of data they generate, inch closer to entering the clinic

Opinion: Ending animal testing could set back xenotransplantation just as the field is poised for a breakthrough

Opinion: Why STAT is sticking with ‘health care’ as two words

STAT+: Trump’s health care affordability czar touts Medicaid cuts to hospital leaders

More health

More Americans survive cancer. But the psychological impacts can persist for years

GLP-1s appear to protect against cancer. Researchers are trying to figure out how

STAT+: GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6B

Alcohol study discarded by Trump officials is published in scientific journal

Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or rest

STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials

STAT+: UnitedHealthcare’s lactation billing feud, and fake strokes

STAT+: Novo underwhelmed by drug it once fought Pfizer for

STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more

STAT+: J&J spends $1 billion to enter KRAS race for cancer treatments

Major readouts from the annual diabetes conference

STAT+: Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rate

In his book, self-described USAID 'whistleblower' talks about the agency and Ebola

MAHA’s Treatments for Autism: Camel’s Milk, Stem Cell Injections — And Spelling Therapy

People love working from home. But does it love them back? A new study says no

Can a vibrating belt help protect bones and muscle health?

By September, Nearly a Third of Americans Will Live in States With Legal Aid in Dying

Reader

Trust & legal

Across the network

Health

Could Your Kid Benefit From Counseling? Experts Offer 3 Questions To Help You Decide

Could Your Kid Benefit From Counseling? Experts Offer 3 Questions To Help You Decide

Trivia Nights, Valentine’s Cards: Overlooked Social Connections Can Prevent Suicide

A leader of the 2014 U.S. Ebola response compares then to now

STAT+: Wearables, and the flood of data they generate, inch closer to entering the clinic

Opinion: Ending animal testing could set back xenotransplantation just as the field is poised for a breakthrough

Opinion: Why STAT is sticking with ‘health care’ as two words

STAT+: Trump’s health care affordability czar touts Medicaid cuts to hospital leaders

More health

More Americans survive cancer. But the psychological impacts can persist for years

GLP-1s appear to protect against cancer. Researchers are trying to figure out how

STAT+: GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6B

Alcohol study discarded by Trump officials is published in scientific journal

Health workers at the epicenter of Congo&#8217;s Ebola outbreak labor with little pay or rest

STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials

STAT+: UnitedHealthcare’s lactation billing feud, and fake strokes

STAT+: Novo underwhelmed by drug it once fought Pfizer for

STAT+: Pharmalittle: We&#8217;re reading about Lilly and Pfizer obesity drug data, Roche and J&#038;J deals, and more

STAT+: J&#038;J spends $1 billion to enter KRAS race for cancer treatments

Major readouts from the annual diabetes conference

STAT+: Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rate

In his book, self-described USAID 'whistleblower' talks about the agency and Ebola

MAHA’s Treatments for Autism: Camel’s Milk, Stem Cell Injections — And Spelling Therapy

People love working from home. But does it love them back? A new study says no

Can a vibrating belt help protect bones and muscle health?

By September, Nearly a Third of Americans Will Live in States With Legal Aid in Dying

Reader

Trust & legal

Across the network

Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or rest

STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more

STAT+: J&J spends $1 billion to enter KRAS race for cancer treatments